InvestorsHub on MSN
RedHill Biopharma shares jump on progress toward treating GLP-1 side effects
RedHill Biopharma Ltd. (NASDAQ:RDHL) shares climbed 16.5% in premarket trading on Monday after the company reported advances ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback